Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sean D Sullivan

Showing results (201-210 of 325) with videos related to

Pageof 33
Sort By:
Medical Decision Making : an International Journal of the Society for Medical Decision Making|March 2, 2019
Estimating Long-Term Survival for Patients with Relapsed or Refractory Large B-Cell Lymphoma Treated with Chimeric Antigen Receptor Therapy: A Comparison of Standard and Mixture Cure ModelsAasthaa Bansal, Sean D Sullivan, Vincent W Lin, et al.
Current Medical Research and Opinion|July 22, 2004
Hospitalization rates among patients with community-acquired pneumonia treated with telithromycin vs clarithromycin: results from two randomized, double-blind, clinical trialsMichael S Niederman, Joanne R Chang, John Stewart, et al.
Addiction (Abingdon, England)|August 17, 2006
The ATTEMPT cohort: a multi-national longitudinal study of predictors, patterns and consequences of smoking cessation; introduction and evaluation of internet recruitment and data collection methodsRobert West, Alicia Gilsenan, Florence Coste, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 3, 2008
HBeAg-negative chronic hepatitis B: cost-effectiveness of peginterferon alfa-2a compared to lamivudine in TaiwanDavid L Veenstra, Sean D Sullivan, Ming-Yang Lai, et al.
Pharmacoeconomics|March 29, 2008
An economic evaluation of atorvastatin for primary prevention of cardiovascular events in type 2 diabetesScott D Ramsey, Lauren D Clarke, Craig S Roberts, et al.
Physical Therapy|August 29, 2015
Role of Health Services Research in Producing High-Value Rehabilitation CareSean D Rundell, Adam P Goode, Janna L Friedly, et al.
Endocrinology, Diabetes & Metabolism|November 22, 2021
Clinical outcomes in high-hypoglycaemia-risk patients with type 2 diabetes switching to insulin glargine 300 U/mL versus a first-generation basal insulin analogue in the United States : Results from the DELIVER High Risk real-world studySean D Sullivan, Nick Freemantle, Rishab A Gupta, et al.
International Journal of Technology Assessment in Health Care|January 12, 2010
Are Key Principles for improved health technology assessment supported and used by health technology assessment organizations?, Peter J Neumann, Michael F Drummond, et al.
Journal of Gastroenterology and Hepatology|August 25, 2007
Cost-effectiveness of peginterferon alpha-2a compared to lamivudine treatment in patients with hepatitis B e antigen positive chronic hepatitis B in TaiwanSean D Sullivan, David L Veenstra, Pei-Jer Chen, et al.
International Journal of Technology Assessment in Health Care|August 6, 2016
EXPANDING EVIDENCE-BASED TECHNOLOGY ASSESSMENT FOR COVERAGE IN WASHINGTON STATEErik J Landaas, Gary Franklin, Jeff Thompson, et al.
Pageof 33

Showing results (201-210 of 325) with videos related to

Sort By:
Pageof 33
Medical Decision Making : an International Journal of the Society for Medical Decision Making|March 2, 2019
Estimating Long-Term Survival for Patients with Relapsed or Refractory Large B-Cell Lymphoma Treated with Chimeric Antigen Receptor Therapy: A Comparison of Standard and Mixture Cure ModelsAasthaa Bansal, Sean D Sullivan, Vincent W Lin, et al.
Current Medical Research and Opinion|July 22, 2004
Hospitalization rates among patients with community-acquired pneumonia treated with telithromycin vs clarithromycin: results from two randomized, double-blind, clinical trialsMichael S Niederman, Joanne R Chang, John Stewart, et al.
Addiction (Abingdon, England)|August 17, 2006
The ATTEMPT cohort: a multi-national longitudinal study of predictors, patterns and consequences of smoking cessation; introduction and evaluation of internet recruitment and data collection methodsRobert West, Alicia Gilsenan, Florence Coste, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 3, 2008
HBeAg-negative chronic hepatitis B: cost-effectiveness of peginterferon alfa-2a compared to lamivudine in TaiwanDavid L Veenstra, Sean D Sullivan, Ming-Yang Lai, et al.
Pharmacoeconomics|March 29, 2008
An economic evaluation of atorvastatin for primary prevention of cardiovascular events in type 2 diabetesScott D Ramsey, Lauren D Clarke, Craig S Roberts, et al.
Physical Therapy|August 29, 2015
Role of Health Services Research in Producing High-Value Rehabilitation CareSean D Rundell, Adam P Goode, Janna L Friedly, et al.
Endocrinology, Diabetes & Metabolism|November 22, 2021
Clinical outcomes in high-hypoglycaemia-risk patients with type 2 diabetes switching to insulin glargine 300 U/mL versus a first-generation basal insulin analogue in the United States : Results from the DELIVER High Risk real-world studySean D Sullivan, Nick Freemantle, Rishab A Gupta, et al.
International Journal of Technology Assessment in Health Care|January 12, 2010
Are Key Principles for improved health technology assessment supported and used by health technology assessment organizations?, Peter J Neumann, Michael F Drummond, et al.
Journal of Gastroenterology and Hepatology|August 25, 2007
Cost-effectiveness of peginterferon alpha-2a compared to lamivudine treatment in patients with hepatitis B e antigen positive chronic hepatitis B in TaiwanSean D Sullivan, David L Veenstra, Pei-Jer Chen, et al.
International Journal of Technology Assessment in Health Care|August 6, 2016
EXPANDING EVIDENCE-BASED TECHNOLOGY ASSESSMENT FOR COVERAGE IN WASHINGTON STATEErik J Landaas, Gary Franklin, Jeff Thompson, et al.
Pageof 33